Hyperkalemia

Continuing ACE Inhibitors Despite Potassium Change Can Have Benefits

Publish Date November 21, 2022

Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.

Patiromer Use for Acute Hyperkalemia Characterized

Publish Date November 18, 2022

Investigators report a low incidence of hypokalemia and hypomagnesemia after a single dose of patiromer monotherapy.

Potassium Binder Use Long Term Linked With Better Outcomes

Publish Date November 17, 2022

Potassium binders historically have been used short term or intermittently.

RAAS Inhibitor Discontinuation After Hyperkalemia Tied to Adverse Outcomes

Publish Date November 16, 2022

Discontinuation of RAAS inhibitors is often the first approach to manage hyperkalemia.

Hyperkalemia Is a Strong Risk Factor for Early Death in Stage 5 CKD

Publish Date November 4, 2022

New findings have important implications in the new era where delaying dialysis initiation is a priority goal by means of continued conservative management of hyperkalemia, according to investigators.

SPS, Patiromer Lower Serum Potassium in Hemodialysis

Publish Date October 6, 2022

Both potassium binders effectively lowered serum potassium levels in patients on hemodialysis meeting hyperkalemia definitions, compared with no treatment, investigators reported.

Nomogram Predicts Hyperkalemia in Patients With CKD

Publish Date September 23, 2022

Patients with a high risk of hyperkalemia according to the nomogram need timely and continuous monitoring of serum potassium, the investigators stated.

Potassium Binders for Hyperkalemia in CKD Compared, Characterized

Publish Date August 31, 2022

Each of the 4 potassium binders that were compared in a study had advantages and disadvantages, investigators reported.

Patiromer Effective for Hyperkalemia Across CKD Stages

Publish Date August 22, 2022

Patiromer was well tolerated in patients with nondialysis-dependent chronic kidney disease stages 1 to 5.

Interdisciplinary Panel Issues Consensus Document for Managing Hyperkalemia

Publish Date August 5, 2022

A committee of nephrologists and cardiologists developed 6 recommendations to improve hyperkalemia management.